An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review
Blood-disseminated Aspergillus spondylitis in immunocompetent individuals is rare. The clinical, imaging, and pathological manifestations of this condition are not specific. Therefore, this disease is prone to misdiagnosis and a missed diagnosis. Systemic antifungal therapy is the main treatment for...
Gespeichert in:
Veröffentlicht in: | Journal of international medical research 2024-04, Vol.52 (4), p.3000605241234574-3000605241234574 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3000605241234574 |
---|---|
container_issue | 4 |
container_start_page | 3000605241234574 |
container_title | Journal of international medical research |
container_volume | 52 |
creator | Dong, Shuangxia Lin, Qianding Dai, Xinjian Lin, Zhou |
description | Blood-disseminated Aspergillus spondylitis in immunocompetent individuals is rare. The clinical, imaging, and pathological manifestations of this condition are not specific. Therefore, this disease is prone to misdiagnosis and a missed diagnosis. Systemic antifungal therapy is the main treatment for Aspergillus spondylitis. We report a case of blood-disseminated Aspergillus versicolor spondylitis in a patient with normal immune function. The first antifungal treatment lasted for 4 months, but Aspergillus spondylitis recurred a few months later. A second antifungal treatment course was initiated for at least 1 year, and follow-up has been ongoing. Currently, there has been no recurrence. |
doi_str_mv | 10.1177/03000605241234574 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3035539103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_03000605241234574</sage_id><sourcerecordid>3049209652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-84d6224553bbc220f5205253242c09dcd312257a854c962c2248810f7beebd7b3</originalsourceid><addsrcrecordid>eNp1kUtrGzEUhUVoiN0kPyCbIuimm3H0nEd3JqQPMGSTrAeNdJ3IzIymupqY_PvKOE2gpasLOt85V9Ih5IqzFedVdc0kY6xkWigupNKVOiFLripZiCx8IMuDXhyABfmIuGNMiVKLM7KQtW4q1ugl2a9H6odhHoMNwwQJxkSfAia69-mJdn0IrnAeEQY_mgSOrnGC-Oj7fkb6DBG9DX2IFKcwupfeJ49fqaHWINAIU4iJmtHRLEA0aY6H02cP-wtyujU9wuXrPCcP327vb34Um7vvP2_Wm8LKUqaiVq4UQmktu84KwbZa5OdqKZSwrHHWSS6ErkytlW1KkRFV15xtqw6gc1Unz8mXY-4Uw68ZMLWDRwt9b0YIM7aSyRzecCYz-vkvdBfmOObbZUo1gjX58zLFj5SNATHCtp2iH0x8aTlrD620_7SSPZ9ek-duAPfm-FNDBlZHAM0jvK_9f-Jvi8GU8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3049209652</pqid></control><display><type>article</type><title>An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Sage Journals GOLD Open Access 2024</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Dong, Shuangxia ; Lin, Qianding ; Dai, Xinjian ; Lin, Zhou</creator><creatorcontrib>Dong, Shuangxia ; Lin, Qianding ; Dai, Xinjian ; Lin, Zhou</creatorcontrib><description>Blood-disseminated Aspergillus spondylitis in immunocompetent individuals is rare. The clinical, imaging, and pathological manifestations of this condition are not specific. Therefore, this disease is prone to misdiagnosis and a missed diagnosis. Systemic antifungal therapy is the main treatment for Aspergillus spondylitis. We report a case of blood-disseminated Aspergillus versicolor spondylitis in a patient with normal immune function. The first antifungal treatment lasted for 4 months, but Aspergillus spondylitis recurred a few months later. A second antifungal treatment course was initiated for at least 1 year, and follow-up has been ongoing. Currently, there has been no recurrence.</description><identifier>ISSN: 0300-0605</identifier><identifier>EISSN: 1473-2300</identifier><identifier>DOI: 10.1177/03000605241234574</identifier><identifier>PMID: 38597095</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Antifungal Agents - therapeutic use ; Aspergillosis - diagnosis ; Aspergillosis - drug therapy ; Aspergillosis - microbiology ; Aspergillus ; Humans ; Spondylarthritis ; Spondylitis - diagnostic imaging ; Spondylitis - drug therapy ; Voriconazole - therapeutic use</subject><ispartof>Journal of international medical research, 2024-04, Vol.52 (4), p.3000605241234574-3000605241234574</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c363t-84d6224553bbc220f5205253242c09dcd312257a854c962c2248810f7beebd7b3</cites><orcidid>0000-0002-5323-2433</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/03000605241234574$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/03000605241234574$$EHTML$$P50$$Gsage$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,864,21966,27853,27924,27925,44945,45333</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38597095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dong, Shuangxia</creatorcontrib><creatorcontrib>Lin, Qianding</creatorcontrib><creatorcontrib>Dai, Xinjian</creatorcontrib><creatorcontrib>Lin, Zhou</creatorcontrib><title>An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review</title><title>Journal of international medical research</title><addtitle>J Int Med Res</addtitle><description>Blood-disseminated Aspergillus spondylitis in immunocompetent individuals is rare. The clinical, imaging, and pathological manifestations of this condition are not specific. Therefore, this disease is prone to misdiagnosis and a missed diagnosis. Systemic antifungal therapy is the main treatment for Aspergillus spondylitis. We report a case of blood-disseminated Aspergillus versicolor spondylitis in a patient with normal immune function. The first antifungal treatment lasted for 4 months, but Aspergillus spondylitis recurred a few months later. A second antifungal treatment course was initiated for at least 1 year, and follow-up has been ongoing. Currently, there has been no recurrence.</description><subject>Antifungal Agents - therapeutic use</subject><subject>Aspergillosis - diagnosis</subject><subject>Aspergillosis - drug therapy</subject><subject>Aspergillosis - microbiology</subject><subject>Aspergillus</subject><subject>Humans</subject><subject>Spondylarthritis</subject><subject>Spondylitis - diagnostic imaging</subject><subject>Spondylitis - drug therapy</subject><subject>Voriconazole - therapeutic use</subject><issn>0300-0605</issn><issn>1473-2300</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kUtrGzEUhUVoiN0kPyCbIuimm3H0nEd3JqQPMGSTrAeNdJ3IzIymupqY_PvKOE2gpasLOt85V9Ih5IqzFedVdc0kY6xkWigupNKVOiFLripZiCx8IMuDXhyABfmIuGNMiVKLM7KQtW4q1ugl2a9H6odhHoMNwwQJxkSfAia69-mJdn0IrnAeEQY_mgSOrnGC-Oj7fkb6DBG9DX2IFKcwupfeJ49fqaHWINAIU4iJmtHRLEA0aY6H02cP-wtyujU9wuXrPCcP327vb34Um7vvP2_Wm8LKUqaiVq4UQmktu84KwbZa5OdqKZSwrHHWSS6ErkytlW1KkRFV15xtqw6gc1Unz8mXY-4Uw68ZMLWDRwt9b0YIM7aSyRzecCYz-vkvdBfmOObbZUo1gjX58zLFj5SNATHCtp2iH0x8aTlrD620_7SSPZ9ek-duAPfm-FNDBlZHAM0jvK_9f-Jvi8GU8Q</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Dong, Shuangxia</creator><creator>Lin, Qianding</creator><creator>Dai, Xinjian</creator><creator>Lin, Zhou</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5323-2433</orcidid></search><sort><creationdate>202404</creationdate><title>An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review</title><author>Dong, Shuangxia ; Lin, Qianding ; Dai, Xinjian ; Lin, Zhou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-84d6224553bbc220f5205253242c09dcd312257a854c962c2248810f7beebd7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>Aspergillosis - diagnosis</topic><topic>Aspergillosis - drug therapy</topic><topic>Aspergillosis - microbiology</topic><topic>Aspergillus</topic><topic>Humans</topic><topic>Spondylarthritis</topic><topic>Spondylitis - diagnostic imaging</topic><topic>Spondylitis - drug therapy</topic><topic>Voriconazole - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dong, Shuangxia</creatorcontrib><creatorcontrib>Lin, Qianding</creatorcontrib><creatorcontrib>Dai, Xinjian</creatorcontrib><creatorcontrib>Lin, Zhou</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of international medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dong, Shuangxia</au><au>Lin, Qianding</au><au>Dai, Xinjian</au><au>Lin, Zhou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review</atitle><jtitle>Journal of international medical research</jtitle><addtitle>J Int Med Res</addtitle><date>2024-04</date><risdate>2024</risdate><volume>52</volume><issue>4</issue><spage>3000605241234574</spage><epage>3000605241234574</epage><pages>3000605241234574-3000605241234574</pages><issn>0300-0605</issn><eissn>1473-2300</eissn><abstract>Blood-disseminated Aspergillus spondylitis in immunocompetent individuals is rare. The clinical, imaging, and pathological manifestations of this condition are not specific. Therefore, this disease is prone to misdiagnosis and a missed diagnosis. Systemic antifungal therapy is the main treatment for Aspergillus spondylitis. We report a case of blood-disseminated Aspergillus versicolor spondylitis in a patient with normal immune function. The first antifungal treatment lasted for 4 months, but Aspergillus spondylitis recurred a few months later. A second antifungal treatment course was initiated for at least 1 year, and follow-up has been ongoing. Currently, there has been no recurrence.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>38597095</pmid><doi>10.1177/03000605241234574</doi><orcidid>https://orcid.org/0000-0002-5323-2433</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-0605 |
ispartof | Journal of international medical research, 2024-04, Vol.52 (4), p.3000605241234574-3000605241234574 |
issn | 0300-0605 1473-2300 |
language | eng |
recordid | cdi_proquest_miscellaneous_3035539103 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Sage Journals GOLD Open Access 2024; PubMed Central; Alma/SFX Local Collection |
subjects | Antifungal Agents - therapeutic use Aspergillosis - diagnosis Aspergillosis - drug therapy Aspergillosis - microbiology Aspergillus Humans Spondylarthritis Spondylitis - diagnostic imaging Spondylitis - drug therapy Voriconazole - therapeutic use |
title | An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A33%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20immunocompetent%20host%20with%20blood-disseminated%20Aspergillus%20versicolor%20spondylitis:%20a%20case%20report%20and%20literature%20review&rft.jtitle=Journal%20of%20international%20medical%20research&rft.au=Dong,%20Shuangxia&rft.date=2024-04&rft.volume=52&rft.issue=4&rft.spage=3000605241234574&rft.epage=3000605241234574&rft.pages=3000605241234574-3000605241234574&rft.issn=0300-0605&rft.eissn=1473-2300&rft_id=info:doi/10.1177/03000605241234574&rft_dat=%3Cproquest_cross%3E3049209652%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3049209652&rft_id=info:pmid/38597095&rft_sage_id=10.1177_03000605241234574&rfr_iscdi=true |